Krishna Institute of Medical Sciences (KIMS) has received board approval to acquire a 51% equity stake in Sarvottam Health Care Private Limited for Rs 80 crore. KIMS, which currently acts as the Operations & Management partner for the Kakinada-based hospital, will now move to a majority ownership model. This strategic move aims to strengthen the hospital chain's presence in Andhra Pradesh, with the transaction expected to close by October 31, 2026.
KIMS to Acquire 51% Stake in Sarvottam Health Care for Rs 80 Crore
KIMS to pay Rs 80 crore for 51% stake in Sarvottam Health Care.
Target company reported a turnover of Rs 84.83 crore for FY 2025-26.
Reader Takeaway: KIMS strengthens Kakinada market presence by transitioning from O&M partner to majority owner, ensuring strategic control.
What just happened
Krishna Institute of Medical Sciences Limited (KIMS) has announced the board's approval to acquire a majority 51% equity stake in Sarvottam Health Care Private Limited. The transaction involves a cash consideration of up to Rs 80 crore for 21,72,713 equity shares. The deal is expected to be completed on or before October 31, 2026.
Why this matters
This acquisition marks a shift in KIMS's business model for the Kakinada-based "Trust Multi Speciality Hospital." Previously serving only as the Operations & Management (O&M) partner, KIMS will now hold majority control. The move allows the company to integrate the facility directly into its corporate structure, potentially allowing for better operational efficiency and capital deployment.
The backstory
Sarvottam Health Care, based in Kakinada, Andhra Pradesh, operates a 183-bed facility. The hospital underwent a major infrastructure upgrade in 2021, adding a G+7 building. The target company has shown steady revenue growth, moving from Rs 74.36 crore in FY 2024 to Rs 84.83 crore in FY 2026.
What changes now
KIMS will transition from an external service provider to the majority owner of the hospital assets. This provides KIMS with a long-term strategic footprint in the Kakinada region, moving beyond short-term management fees to capturing the underlying value of the hospital operations.
Governance and Compliance
KIMS has clarified that this acquisition does not qualify as a Related Party Transaction under current regulations. The deal does not require any additional government or regulatory approvals to proceed.
What to track next
Investors should monitor the integration of the hospital’s patient care and management systems into the broader KIMS network. The realization of operational synergies will be key to determining the return on the Rs 80 crore investment.
